Meet in Italy for Life Sciences Brokerage Event 2026

13 – 14 Oct 2026 | Roma, Italy

TarGLiO

Company/Start-up

Barcelona, Spain
21 profile visits

About

TarGLiO is a therapeutic platform for the treatment of glioblastoma based on iron‑oxide magnetic nanoparticles. After intravenous administration, they are designed to reach and preferentially accumulate in the brain tumor, allowing their localization to be visualized by magnetic resonance imaging (MRI) and subsequently enabling the generation of localized hyperthermia through the application of an external alternating magnetic field.

Areas of activity

Life Science Domain

PharmaMedtechResearch

Pharma

Advanced therapy medicinal products (ATMPs)Oncology

Research

Academic spin-offs & start-upsNanomedicine & biomaterials

Representatives

CTO

TarGLiO